| 08/14/2026 4:19 PM | enGene (1980845) Subject PERCEPTIVE ADVISORS LLC (1224962) Filed by | Form SCHEDULE 13G/A | |
| 08/14/2026 3:49 PM | enGene (1980845) Subject Venrock Healthcare Capital Partners III, L.P. (1738048) Filed by | Form SCHEDULE 13G/A | |
| 08/14/2026 7:25 AM | Deep Track Capital, LP (1856083) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 08/13/2026 10:40 AM | enGene (1980845) Subject Invus Global Management, LLC (2005369) Filed by | Form SCHEDULE 13G/A | |
| 08/11/2026 3:03 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/22/2026 3:05 PM | enGene (1980845) Issuer Richton Kathleen P. (2145406) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/22/2026 3:05 PM | Chinoporos Constantine (2014509) Reporting enGene (1980845) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/22/2026 8:14 AM | ACORN BIOVENTURES, L.P. (1766853) Filed by enGene (1980845) Subject | Form SCHEDULE 13G | |
| 07/17/2026 3:05 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/16/2026 7:06 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/18/2026 3:06 PM | enGene (1980845) Filer | Form 8-K/A | |
Get the Latest News and Ratings for ENGNW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for enGene and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/17/2026 4:35 PM | enGene (1980845) Issuer Zoth Lota S. (1278219) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:38 PM | enGene (1980845) Issuer Heffernan Michael Thomas (1448914) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:39 PM | enGene (1980845) Issuer HASTINGS PAUL J (1309702) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:40 PM | enGene (1980845) Issuer Grossman William (1730229) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:41 PM | enGene (1980845) Issuer Glickman Richard M (1352637) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:43 PM | BRUNK GERALD A (1380226) Reporting enGene (1980845) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:44 PM | Astley-Sparke Philip (1376491) Reporting enGene (1980845) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:37 PM | enGene (1980845) Issuer Joustra Wouter (1897813) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 8:14 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/15/2026 8:16 AM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 06/10/2026 3:09 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 12:12 PM | Cormorant Asset Management, LP (1583977) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 05/14/2026 9:30 AM | BML Investment Partners, L.P. (1373604) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 05/13/2026 8:23 PM | BML Investment Partners, L.P. (1373604) Filed by enGene (1980845) Subject | Form SCHEDULE 13G | |
| 05/08/2026 3:06 PM | enGene (1980845) Filer | Form DEF 14A | |
| 05/07/2026 6:11 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/05/2026 9:59 AM | enGene (1980845) Subject Invus Global Management, LLC (2005369) Filed by | Form SCHEDULE 13G/A | |
| 04/09/2026 3:02 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 11:20 AM | enGene (1980845) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/09/2026 6:25 AM | enGene (1980845) Filer | Form 424B5 | |
| 03/09/2026 6:09 AM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 03/09/2026 6:15 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 6:04 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/02/2026 11:15 PM | enGene (1980845) Filer | Form EFFECT | |
| 02/19/2026 3:25 PM | enGene (1980845) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 02/17/2026 5:09 PM | enGene (1980845) Subject Venrock Healthcare Capital Partners III, L.P. (1738048) Filed by | Form SCHEDULE 13G/A | |
| 02/17/2026 2:00 PM | Cormorant Asset Management, LP (1583977) Filed by enGene (1980845) Subject | Form SCHEDULE 13G | |
| 02/17/2026 11:46 AM | enGene (1980845) Subject Kynam Capital Management, LP (1907884) Filed by | Form SCHEDULE 13G/A | |
| 01/27/2026 1:18 PM | enGene (1980845) Subject Invus Global Management, LLC (2005369) Filed by | Form SCHEDULE 13G | |
| 01/21/2026 6:38 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
The end may be near for these iconic stocks (Ad) Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. Watch Marc Chaikin's free presentation and get his full buy-and-sell list today |
| 12/22/2025 3:11 PM | enGene (1980845) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:04 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 7:12 AM | Deep Track Capital, LP (1856083) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 11/14/2025 6:01 AM | enGene (1980845) Filer | Form 424B5 | |
| 11/12/2025 5:16 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/30/2025 6:36 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 3:44 PM | enGene (1980845) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 09/11/2025 3:08 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 3:11 PM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/03/2025 6:56 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |